Guidance on evidence generation on new tuberculosis diagnostics
Published . Updated .
Guidance on evidence generation on new tuberculosis diagnostics World Health Organization (WHO)
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
A fund of health-care companies
- XBI SPDR S&P Biotech
A fund of biotechnology companies
- UNH UnitedHealth
A large health insurer
- JNJ Johnson & Johnson
A large health-care company
- LLY Eli Lilly
A large drug maker
- PFE Pfizer
A large drug maker
Price reaction, T-5 to T+3
Guidance on evidence generation on new tuberculosis diagnostics World Health Organization (WHO)
Source: World Health Organization (WHO)
This story
12 out of 100
“Guidance on evidence generation on new tuberculosis diagnostics” scores 12 out of 100. The score uses 1 sources.